A detailed history of Strong Tower Advisory Services transactions in Abb Vie Inc. stock. As of the latest transaction made, Strong Tower Advisory Services holds 8,699 shares of ABBV stock, worth $1.69 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
8,699
Previous 6,436 35.16%
Holding current value
$1.69 Million
Previous $1.17 Million 27.41%
% of portfolio
0.51%
Previous 0.47%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$154.79 - $180.76 $350,289 - $409,059
2,263 Added 35.16%
8,699 $1.49 Million
Q1 2024

Apr 12, 2024

BUY
$159.82 - $182.1 $125,139 - $142,584
783 Added 13.85%
6,436 $1.17 Million
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $49,811 - $56,099
362 Added 6.84%
5,653 $876,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $14,160 - $16,392
106 Added 2.04%
5,291 $788,000
Q2 2023

Jul 13, 2023

BUY
$132.51 - $164.9 $38,162 - $47,491
288 Added 5.88%
5,185 $698,000
Q1 2023

Apr 14, 2023

BUY
$144.61 - $166.54 $16,485 - $18,985
114 Added 2.38%
4,897 $780,000
Q4 2022

Jan 20, 2023

SELL
$138.31 - $165.87 $12,586 - $15,094
-91 Reduced 1.87%
4,783 $0
Q3 2022

Oct 14, 2022

BUY
$134.21 - $153.93 $5,771 - $6,618
43 Added 0.89%
4,874 $654,000
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $39,221 - $49,863
-285 Reduced 5.57%
4,831 $740,000
Q1 2022

Apr 14, 2022

BUY
$131.98 - $163.75 $29,167 - $36,188
221 Added 4.51%
5,116 $829,000
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $23,742 - $30,040
221 Added 4.73%
4,895 $663,000
Q3 2021

Oct 29, 2021

BUY
$106.4 - $120.78 $497,313 - $564,525
4,674 New
4,674 $507,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Strong Tower Advisory Services Portfolio

Follow Strong Tower Advisory Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strong Tower Advisory Services, based on Form 13F filings with the SEC.

News

Stay updated on Strong Tower Advisory Services with notifications on news.